LiFUS-Mediated BBB Opening for Targeted Neurodegenerative Therapy
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The blood-brain barrier (BBB) restricts the penetration of therapeutic molecules into the brain, limiting the efficacy of treatments for neurodegenerative disorders, and existing drug delivery techniques are invasive, risky, or lack site-specificity and control over drug release.
Innovation Solution
Using low-intensity focused ultrasound (LiFUS) to open the BBB dynamically and deliver therapeutic agents to targeted brain sites, guided by imaging, microbubble cavitation, optical, and physiological parameters.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If the BBB is permanently opened to allow therapeutic molecules to pass, then drug delivery efficiency is improved, but safety deteriorates due to pathogen infiltration risk
Solution Approach 1:
The patent applies dynamic control of BBB permeability by using focused ultrasound to temporarily and reversibly open the blood-brain barrier. The barrier transitions from a closed state (protecting against pathogens) to an open state (allowing drug delivery) and back to closed, enabling controlled access without permanent compromise to barrier integrity or safety
Solution Approach 2:
The invention employs periodic ultrasound application to create transient openings in the BBB. The ultrasound is applied in controlled pulses that temporarily increase barrier permeability for drug delivery, then allow the barrier to close, creating a rhythmic open-close cycle that enables repeated therapeutic access while maintaining long-term protection
2Productivity
If invasive techniques such as convection-enhanced delivery are used to increase drug diffusion into the CNS, then drug delivery efficiency is improved, but device complexity and surgical risk increase
Solution Approach 1:
The patent replaces complex mechanical invasive delivery systems (such as convection-enhanced delivery catheters and pumps) with a non-invasive focused ultrasound system. The ultrasound waves mechanically disrupt the BBB through cavitation and acoustic radiation pressure without requiring physical insertion of delivery devices into the brain, thereby simplifying the overall system and eliminating surgical risks
Solution Approach 2:
The invention introduces microbubbles as an intermediary agent that mediates between the ultrasound energy and the BBB. These microbubbles serve as acoustic contrast agents that amplify the mechanical effect of ultrasound on the barrier, enhancing drug delivery efficiency without requiring direct mechanical invasion of the CNS by complex delivery devices
3Object-affected harmful factors
If non-invasive delivery techniques such as intranasal delivery are used, then surgical risk is reduced, but site-specific bio-distribution and control over drug release deteriorate
Solution Approach 1:
The patent applies local quality enhancement by using focused ultrasound to create spatially selective openings in the BBB at precisely defined target sites. The ultrasound energy is focused to a specific location in the brain, creating localized barrier disruption only at the intended target, thereby achieving site-specific drug delivery with high spatial precision while maintaining non-invasive administration
Solution Approach 2:
The invention incorporates feedback control through real-time imaging guidance (such as MRI or ultrasound imaging) to monitor the location and extent of BBB opening. This feedback allows dynamic adjustment of ultrasound parameters to ensure precise targeting and controlled drug release, compensating for anatomical variations and maintaining high spatial precision throughout the delivery process
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Facilitates targeted and controlled delivery of therapeutic agents across the BBB, enhancing treatment efficacy for neurodegenerative disorders while minimizing invasiveness and side effects.
Implementation Method 1
using focused ultrasound, including LiFUS, to open the BBB
Implementation Method 2
a microbubble cavitation
Implementation Method 3
applying LiFUS sonication via an ultrasound delivery device to the target site
Data Source
AI summary
A method of improving a neurodegenerative or cognitive disorder in a human patient suffering therefrom is provided by determining a target site of the human patient's brain that is affected by the neurodegenerative disorder or cognitive disorder and providing a therapy to the human patient. The therapy includes applying a low intensity focused ultrasound (LiFUS) sonication via an ultrasound delivery device to the target site based on an imaging parameter, a microbubble cavitation; an optical parameter, a bodily fluid parameter, or a physiological or anatomical parameter of the human patient's brain. A therapeutic agent is introduced to the target site before, after or during application of the LiFUS sonication.